RA
BIOL

Royce & Associates’s Biolase, Inc. BIOL Stock Holding History

Royce & Associates’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-13
Closed -$336K – 1253
2015
Q1 		$336K Buy
+13
New +$368K ﹤0.01% 1105

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return

Royce & Associates's BIOL Position: Q2 2015 in Review

Royce & Associates sold out of Biolase, Inc. (BIOL) in Q2 2015, closing a stake of 13 shares — an estimated $336K sold.

Royce & Associates first reported a position in BIOL in Q1 2015 and held it in 1 quarter. The position peaked at $336K in Q1 2015. 34 funds tracked by Wall St. Rank hold BIOL as of Q2 2015.

  • Royce & Associates reported no remaining Biolase, Inc. position as of Q2 2015 after selling out during the quarter.
  • Royce & Associates sold 13 Biolase, Inc. shares in Q2 2015, an estimated $336K.
  • Royce & Associates first reported a position in Biolase, Inc. in Q1 2015 and held it in 1 quarter.
  • Royce & Associates's Biolase, Inc. position peaked at $336K in Q1 2015.
  • 34 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2015.

Based on Royce & Associates's 13F filing for Q2 2015, filed 10 Aug 2015.